These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6713322)

  • 1. Should dopamine agonists be given early or late? A review of nine years experience with bromocriptine.
    Lieberman AN; Gopinathan G; Hassouri H; Neophytides A; Goldstein M
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):233-7. PubMed ID: 6713322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine in Parkinson disease.
    Lieberman AN; Goldstein M
    Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of parkinson's disease with bromocriptine.
    Lieberman A; Kupersmith M; Estey E; Goldstein M
    N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine in Parkinson disease: further studies.
    Lieberman AN; Kupersmith M; Gopinathan G; Estey E; Goodgold A; Goldstein M
    Neurology; 1979 Mar; 29(3):363-9. PubMed ID: 571981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-1 and D-2 agonists in Parkinson's disease.
    Lieberman AN; Goldstein M; Gopinathan G; Neophytides A
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):466-73. PubMed ID: 2960431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.
    Rinne UK
    Neurology; 1987 May; 37(5):826-8. PubMed ID: 3574685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should dopamine agonists be given early or late in the treatment of Parkinson's disease?
    Rascol A; Montastruc JL; Rascol O
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):229-32. PubMed ID: 6713321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.
    Jansen EN; Meerwaldt JD
    Adv Neurol; 1987; 45():539-42. PubMed ID: 3103396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
    Montastruc JL; Rascol O; Rascol A
    Rev Neurol (Paris); 1990; 146(2):144-7. PubMed ID: 2181588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of parkinsonism with bromocriptine.
    Calne DB; Plotkin C; Williams AC; Nutt JG; Neophytides A; Teychenne PF
    Lancet; 1978 Apr; 1(8067):735-8. PubMed ID: 76747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term experience with bromocriptine in advanced parkinsonism. Results after one year's treatment.
    Schneider E; Fischer PA
    J Neurol; 1982; 228(4):249-58. PubMed ID: 6188812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine in parkinsonism. A long-term study.
    Lees AJ; Haddad S; Shaw KM; Kohout LJ; Stern GM
    Arch Neurol; 1978 Aug; 35(8):503-5. PubMed ID: 666607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined bromocriptine-levodopa therapy early in Parkinson's disease.
    Rinne UK
    Neurology; 1985 Aug; 35(8):1196-8. PubMed ID: 4022354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
    Kartzinel R; TEYCHENNE P; Gillespie MM; Perlow M; Gielen AC; Sadowsky DA; Calne DB
    Lancet; 1976 Aug; 2(7980):272-5. PubMed ID: 59850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of bromocriptine in Parkinson disease.
    Lieberman A; Kupersmith M; Neophytides A; Casson I; Durso R; Foo SH; Khayali M; Bear G; Goldstein M
    Neurology; 1980 May; 30(5):518-23. PubMed ID: 6768003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
    Teychenne PF; Bergsrud D; Elton RL; Racy A
    Clin Neuropharmacol; 1986; 9(2):138-45. PubMed ID: 3708599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
    Bonnet AM; Serre I; Marconi R; Agid Y; Dubois B
    Mov Disord; 1995 Sep; 10(5):668-71. PubMed ID: 8552122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine versus levodopa in early Parkinson's disease.
    Ramaker C; van Hilten JJ
    Cochrane Database Syst Rev; 2000; (3):CD002258. PubMed ID: 10908538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
    Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
    Jellinger K
    J Neurol; 1982; 227(2):75-88. PubMed ID: 6180142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.